Literature DB >> 8551603

Mutational analysis of human papillomavirus type 16 E6 demonstrates that p53 degradation is necessary for immortalization of mammary epithelial cells.

S Dalal1, Q Gao, E J Androphy, V Band.   

Abstract

We have previously demonstrated that normal human mammary epithelial cells (MECs) are efficiently immortalized by human papillomavirus type 16 (HPV16) E6. HPV16 E6 binds to and induces p53 degradation in vitro and induces a marked reduction of p53 protein in MECs. Low-risk HPV6 E6 is defective for p53 binding and degradation in vitro but immortalized MECs at low efficiency. The HPV6 E6-immortalized MECs had markedly reduced levels of p53. To directly investigate whether the ability of HPV16 E6 to stimulate p53 degradation is required for E6-induced immortalization, a series of HPV16 E6 mutants were analyzed for the ability to bind and degrade p53 in vitro, induce a reduction in p53 levels in vivo, and immortalize MECs. We observed that one set of mutants efficiently immortalized MECs, caused a reduction in p53 levels in vivo, and degraded p53 in vitro. Other mutants immortalized MECs with low efficiency and either induced p53 degradation at low levels or were unable to induce p53 degradation in vitro; however, all of the immortal clones displayed low levels of p53. A third class of mutants did not immortalize MECs and failed to induce a reduction in p53 levels in vivo or degrade p53 in vitro. These results demonstrate that a reduction in p53 protein levels due to enhanced degradation is essential for MEC immortalization by HPV16 E6.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551603      PMCID: PMC189867     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes.

Authors:  M S Barbosa; R Schlegel
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

2.  The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.

Authors:  K Münger; W C Phelps; V Bubb; P M Howley; R Schlegel
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

3.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

Authors:  V Band; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells.

Authors:  M A Bedell; K H Jones; S R Grossman; L A Laimins
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53.

Authors:  M Scheffner; J M Huibregtse; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Tumor cell-specific loss of p53 protein in a unique in vitro model of human breast tumor progression.

Authors:  X L Liu; H Band; Q Gao; D E Wazer; Q Chu; V Band
Journal:  Carcinogenesis       Date:  1994-09       Impact factor: 4.944

7.  Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7.

Authors:  D E Wazer; X L Liu; Q Chu; Q Gao; V Band
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

9.  Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines.

Authors:  E J Androphy; N L Hubbert; J T Schiller; D R Lowy
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

10.  HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

Authors:  P Hawley-Nelson; K H Vousden; N L Hubbert; D R Lowy; J T Schiller
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  39 in total

1.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

4.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

5.  Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model.

Authors:  A Carnero; J D Hudson; G J Hannon; D H Beach
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

6.  A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects.

Authors:  S Peng; T T Tomson; C Trimble; L He; C-F Hung; T-C Wu
Journal:  Gene Ther       Date:  2006-02       Impact factor: 5.250

Review 7.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

8.  The PDZ binding motif of human papillomavirus type 16 E6 induces PTPN13 loss, which allows anchorage-independent growth and synergizes with ras for invasive growth.

Authors:  William C Spanos; Andrew Hoover; George F Harris; Shu Wu; Guinevere L Strand; Mary E Anderson; Aloysius J Klingelhutz; Wiljan Hendriks; Aaron D Bossler; John H Lee
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

9.  Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3.

Authors:  Ajay Kumar; Yongtong Zhao; Gaoyuan Meng; Musheng Zeng; Seetha Srinivasan; Laurie M Delmolino; Qingshen Gao; Goberdhan Dimri; Georg F Weber; David E Wazer; Hamid Band; Vimla Band
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.

Authors:  Timothy M Chlon; Elizabeth E Hoskins; Christopher N Mayhew; Kathryn A Wikenheiser-Brokamp; Stella M Davies; Parinda Mehta; Kasiani C Myers; James M Wells; Susanne I Wells
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.